What is Leerink Partnrs’ Estimate for PTCT FY2026 Earnings?
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Leerink Partnrs raised their FY2026 earnings per share (EPS) estimates for PTC Therapeutics in a report issued on Tuesday, April 29th. Leerink Partnrs analyst J. Schwartz now expects that the biopharmaceutical company will post earnings of ($2.58) per share for the year, up from their previous estimate […]
